BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xue T, Jia Q, Ge N, Zhang B, Wang Y, Ren Z, Ye S. The platelet-to-lymphocyte ratio predicts poor survival in patients with huge hepatocellular carcinoma that received transarterial chemoembolization. Tumor Biol 2015;36:6045-51. [DOI: 10.1007/s13277-015-3281-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Usta A, Gemcioglu E, Baser S, Ersoy O, Polat YH, Erden A, Izdes S. Comparison of APACHE II scores and mortality with CRP/albumin, neutrophil/lymphocyte and thrombocyte/lymphocyte ratios in patients admitted to internal medicine and anesthesia reanimation intensive care unit. LaboratoriumsMedizin 2022;46:23-31. [DOI: 10.1515/labmed-2021-0061] [Reference Citation Analysis]
2 石 攀. Research Progress of Preoperative Immune Nutrition Score and Prognosis of Malignant Tumor. ACM 2022;12:10772-10777. [DOI: 10.12677/acm.2022.12111552] [Reference Citation Analysis]
3 Young S, Cam I, Gencturk M, Rubin N, D'souza D, Flanagan S, Golzarian J, Sanghvi T. Inflammatory Scores: Comparison and Utility in HCC Patients Undergoing Transarterial Chemoembolization in a North American Cohort. J Hepatocell Carcinoma 2021;8:1513-24. [PMID: 34881208 DOI: 10.2147/JHC.S335183] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Chen L, Ke Z, Xiong F, Kan X, Ren Y, Cao Y, Sun T, Yan L, Zhou G, Zheng C. Platelet-to-lymphocyte ratio predicts therapy outcomes of transarterial chemoembolization plus apatinib in the treatment of advanced hepatocellular carcinoma. Anticancer Drugs 2020;31:966-72. [PMID: 31977568 DOI: 10.1097/CAD.0000000000000913] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Lu LH, Wei W, Li SH, Zhang YF, Guo RP. The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE. Aging (Albany NY) 2021;13:5358-68. [PMID: 33589570 DOI: 10.18632/aging.202468] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
6 Yang Y, Wang MC, Tian T, Huang J, Yuan SX, Liu L, Zhu P, Gu FM, Fu SY, Jiang BG, Liu FC, Pan ZY, Zhou WP. A High Preoperative Platelet-Lymphocyte Ratio Is a Negative Predictor of Survival After Liver Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Retrospective Study. Front Oncol 2020;10:576205. [PMID: 33178607 DOI: 10.3389/fonc.2020.576205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
7 Karaoğullarindan Ü, Akkiz H, Kuran S, Uskudar O, Taskaynatan H, Delik A. The Relationship Between Thrombocyte Lymphocyte Ratio With Tumor Morphology and Alpha Fetoprotein in Patients with Hepatocellular Carcinoma. Turkish Journal of Family Medicine and Primary Care 2020. [DOI: 10.21763/tjfmpc.659799] [Reference Citation Analysis]
8 Schobert IT, Savic LJ, Chapiro J, Bousabarah K, Chen E, Laage-Gaupp F, Tefera J, Nezami N, Lin M, Pollak J, Schlachter T. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. Eur Radiol 2020;30:5663-73. [PMID: 32424595 DOI: 10.1007/s00330-020-06931-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
9 Li S, Feng X, Cao G, Wang Q, Wang L. Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis. PLoS One 2020;15:e0230879. [PMID: 32214401 DOI: 10.1371/journal.pone.0230879] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
10 Kong W, Zheng J, Chen L, Zuo X, Wang H, Wang X, Yao J, Chen W. Mean corpuscular hemoglobin concentration correlates with prognosis of resected hepatocellular carcinoma. Biomark Med 2020;14:259-70. [PMID: 32134324 DOI: 10.2217/bmm-2019-0224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Zhu DD, Liu X. Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Branch Retinal Vein Occlusion. J Ophthalmol 2019;2019:6043612. [PMID: 31885890 DOI: 10.1155/2019/6043612] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
12 Shen Y, Wang H, Chen X, Li W, Chen J. Prognostic significance of lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization and radiofrequency ablation. Onco Targets Ther 2019;12:7129-37. [PMID: 31564897 DOI: 10.2147/OTT.S217935] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
13 Wang B, Li F, Cheng L, Zhan Y, Wu B, Chen P, Shen J, Wu W, Ma X, Zhu J, Pan B, Guo W, Cheng Y. The pretreatment platelet count is an independent predictor of tumor progression in patients undergoing transcatheter arterial chemoembolization with hepatitis B virus-related hepatocellular carcinoma. Future Oncology 2019;15:827-39. [DOI: 10.2217/fon-2018-0591] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Rungsakulkij N, Mingphruedhi S, Suragul W, Tangtawee P, Muangkaew P, Aeesoa S. Platelet-to-Lymphocyte Ratio and Large Tumor Size Predict Microvascular Invasion after Resection for Hepatocellular Carcinoma. Asian Pac J Cancer Prev 2018;19:3435-41. [PMID: 30583666 DOI: 10.31557/APJCP.2018.19.12.3435] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
15 Quiros-Roldan E, Properzi M, Amadasi S, Raffetti E, Ferraresi A, Biasi L, Focà E, Castelli F. Prognostic role of inflammatory biomarkers in HIV-infected patients with a first diagnosis of hepatocellular carcinoma: A single-center study. J Med Virol 2019;91:241-8. [PMID: 30216474 DOI: 10.1002/jmv.25317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Lin WF, Zhong MF, Zhang YR, Wang H, Zhao HT, Cheng BB, Ling CQ. Prognostic Role of Platelet-to-Lymphocyte Ratio in Hepatocellular Carcinoma with Different BCLC Stages: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract 2018;2018:5670949. [PMID: 30158964 DOI: 10.1155/2018/5670949] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
17 Aryal B, Yamakuchi M, Shimizu T, Kadono J, Furoi A, Gejima K, Komokata T, Hashiguchi T, Imoto Y. Deciphering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma. Can J Gastroenterol Hepatol 2018;2018:9142672. [PMID: 30050894 DOI: 10.1155/2018/9142672] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
18 Suner A, Carr BI, Akkiz H, Uskudar O, Kuran S, Tokat Y, Tokmak S, Ballı T, Ulku A, AkCam T, Delik A, Arslan B, Doran F, YalCın K, Ekinci N, Yilmaz S, Ozakyol A, Yücesoy M, BahCeci HI, Polat KY, Şimsek H, Ormeci N, Sonsuz A, Demir M, KılıC M, Uygun A, Demir A, Altıntas E, Karakulah G, Temel T, Bektas A. Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics. J Transl Sci 2019;5. [PMID: 30662766 DOI: 10.15761/JTS.1000260] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
19 Song W, Wang K, Zhong FP, Fan YW, Peng L, Zou SB. Clinicopathological and prognostic significance of platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma. Oncotarget 2016;7:81830-8. [PMID: 27833084 DOI: 10.18632/oncotarget.13244] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
20 Guo J, Wu M, Guo L, Zuo Q. Pretreatment blood neutrophil/lymphocyte ratio is associated with metastasis and predicts survival in patients with pancreatic cancer. Bull Cancer 2018;105:146-54. [PMID: 29290332 DOI: 10.1016/j.bulcan.2017.10.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
21 Rosenblatt RE, Tafesh ZH, Halazun KJ. Role of inflammatory markers as hepatocellular cancer selection tool in the setting of liver transplantation. Transl Gastroenterol Hepatol 2017;2:95. [PMID: 29264433 DOI: 10.21037/tgh.2017.10.04] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
22 Zhao Y, Si G, Zhu F, Hui J, Cai S, Huang C, Cheng S, Fathy AH, Xiang Y, Li J. Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 2017;8:22854-62. [PMID: 28206965 DOI: 10.18632/oncotarget.15281] [Cited by in Crossref: 27] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
23 Zhu L, Li T, Ma X, Qiu Y, Ma X, Lin Y, Han L, Qin C. A Simple Noninvasive Index Can Predict Hepatocellular Carcinoma in Patients with Chronic Hepatitis B. Sci Rep 2017;7:8954. [PMID: 28827721 DOI: 10.1038/s41598-017-09358-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
24 Yang HJ, Jiang JH, Liu QA, Zhou CM, Du YF, Wu T, Chen NZ, Xiang BD. Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection. Tumour Biol. 2017;39:1010428317707375. [PMID: 28639906 DOI: 10.1177/1010428317707375] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
25 Xia W, Ke Q, Guo H, Wang W, Zhang M, Shen Y, Wu J, Xu X, Yan S, Yu J, Zhang M, Zheng S. Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio. BMC Cancer. 2017;17:14. [PMID: 28056901 DOI: 10.1186/s12885-016-3028-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
26 Ma W, Zhang P, Qi J, Gu L, Zang M, Yao H, Shi X, Wang C, Jiang Y. Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis. Sci Rep 2016;6:35378. [PMID: 27739490 DOI: 10.1038/srep35378] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
27 Meng X, Wei G, Chang Q, Peng R, Shi G, Zheng P, He F, Wang W, Ming L. The platelet-to-lymphocyte ratio, superior to the neutrophil-to-lymphocyte ratio, correlates with hepatitis C virus infection. Int J Infect Dis. 2016;45:72-77. [PMID: 26948479 DOI: 10.1016/j.ijid.2016.02.025] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
28 Dong P, Ma L, Liu L, Zhao G, Zhang S, Dong L, Xue R, Chen S. CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis. Int J Mol Sci 2016;17:320. [PMID: 26938527 DOI: 10.3390/ijms17030320] [Cited by in Crossref: 81] [Cited by in F6Publishing: 96] [Article Influence: 13.5] [Reference Citation Analysis]
29 Ji F, Liang Y, Fu SJ, Guo ZY, Shu M, Shen SL, Li SQ, Peng BG, Liang LJ, Hua YP. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI). BMC Cancer 2016;16:137. [PMID: 26907597 DOI: 10.1186/s12885-016-2189-1] [Cited by in Crossref: 68] [Cited by in F6Publishing: 75] [Article Influence: 11.3] [Reference Citation Analysis]
30 D'Alessandro R, Messa C, Refolo MG, Carr BI. Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCC. Expert Opin Pharmacother 2015;16:2773-80. [PMID: 26479083 DOI: 10.1517/14656566.2015.1101065] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]